Istradefylline for Parkinson Disease With Cognitive Impairment
Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether istradefylline improves cognition
in individuals with Parkinson disease with cognitive impairment.